PanCAN Senior Director of Patient Services Fatima Zelada-Arenas talks about the process of working through grief and offers ...

Each year, the National Cancer Institute (NCI) shares critical updates on the state of cancer in the United States. In the latest Annual Report to the Nation on the Status of Cancer, there is good ...

Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...

For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...

Editor’s note: November is Pancreatic Cancer Awareness Month. Throughout the month, we are sharing stories to raise awareness of the signs and symptoms of the disease and the importance of early ...

A team of researchers recently published a paper in the journal Nature that caught the attention of news media and all those affected by pancreatic cancer. Although a small, early phase clinical trial ...

Editor’s Note: “Five Key Facts About PNETs” was originally published in February 2020. Here, we update that blog post with new information in light of an announcement from television personality Maria ...